121 related articles for article (PubMed ID: 1967149)
1. Treatment of lymphoma with radiolabeled antibody: elimination of tumor cells lacking target antigen.
Nourigat C; Badger CC; Bernstein ID
J Natl Cancer Inst; 1990 Jan; 82(1):47-50. PubMed ID: 1967149
[TBL] [Abstract][Full Text] [Related]
2. Experimental radioimmunotherapy of murine lymphoma with 131I-labeled anti-T-cell antibodies.
Badger CC; Krohn KA; Shulman H; Flournoy N; Bernstein ID
Cancer Res; 1986 Dec; 46(12 Pt 1):6223-8. PubMed ID: 3779642
[TBL] [Abstract][Full Text] [Related]
3. Experimental radiotherapy of murine lymphoma with 131I-labeled anti-Thy 1.1 monoclonal antibody.
Badger CC; Krohn KA; Peterson AV; Shulman H; Bernstein ID
Cancer Res; 1985 Apr; 45(4):1536-44. PubMed ID: 3978621
[TBL] [Abstract][Full Text] [Related]
4. Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen.
Badger CC; Bernstein ID
J Exp Med; 1983 Mar; 157(3):828-42. PubMed ID: 6403649
[TBL] [Abstract][Full Text] [Related]
5. High dose radiolabeled antibody therapy of lymphoma.
Bernstein ID; Eary JF; Badger CC; Press OW; Appelbaum FR; Martin PJ; Krohn KA; Nelp WB; Porter B; Fisher D
Cancer Res; 1990 Feb; 50(3 Suppl):1017s-1021s. PubMed ID: 2297714
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I.
Badger CC; Davis J; Nourigat C; Wu ZM; Hui TE; Fisher DR; Shulman H; Appelbaum FR; Eary JF; Krohn KA
Cancer Res; 1991 Nov; 51(21):5921-8. PubMed ID: 1682038
[TBL] [Abstract][Full Text] [Related]
7. Influence of antibody isotype on passive serotherapy of lymphoma.
Denkers EY; Badger CC; Ledbetter JA; Bernstein ID
J Immunol; 1985 Sep; 135(3):2183-6. PubMed ID: 2862210
[TBL] [Abstract][Full Text] [Related]
8. Prospects for monoclonal antibody therapy of leukemia and lymphoma.
Badger CC; Bernstein ID
Cancer; 1986 Jul; 58(2 Suppl):584-9. PubMed ID: 3521840
[TBL] [Abstract][Full Text] [Related]
9. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
Buchsbaum DJ; Wahl RL; Normolle DP; Kaminski MS
Cancer Res; 1992 Dec; 52(23):6476-81. PubMed ID: 1423295
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody therapy of spontaneous AKR T-cell leukemia.
Badger CC; Shulman H; Peterson AV; Bernstein ID
Cancer Res; 1986 Aug; 46(8):4058-63. PubMed ID: 2873885
[TBL] [Abstract][Full Text] [Related]
11. Influence of endogenous Thy1.1 cells upon the efficacy of an anti-Thy1.1 antibody-diphtheria toxin conjugate.
Yan B; Baker PD; Evans CH; Marsh JW
Bioconjug Chem; 1991; 2(4):207-10. PubMed ID: 1685330
[TBL] [Abstract][Full Text] [Related]
12. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
13. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
Colapinto EV; Zalutsky MR; Archer GE; Noska MA; Friedman HS; Carrel S; Bigner DD
Cancer Res; 1990 Mar; 50(6):1822-7. PubMed ID: 2407345
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants.
Thorpe PE; Blakey DC; Brown AN; Knowles PP; Knyba RE; Wallace PM; Watson GJ; Wawrzynczak EJ
J Natl Cancer Inst; 1987 Nov; 79(5):1101-12. PubMed ID: 2890786
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution of p-iodobenzoyl (PIP) labeled antibodies in a murine lymphoma model.
Badger CC; Wilbur DS; Hadley SW; Fritzberg AR; Bernstein ID
Int J Rad Appl Instrum B; 1990; 17(4):381-7. PubMed ID: 2387747
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
[TBL] [Abstract][Full Text] [Related]
18. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis treatment of ME-180 human cervical carcinoma model with 131I-labeled TNT-1 monoclonal antibody.
Chen FM; Taylor CR; Epstein AL
Cancer Res; 1989 Aug; 49(16):4578-85. PubMed ID: 2743341
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM
Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
